This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1968 and headquartered in Cincinnati, OH, Cintas Corporation provides specialized services to businesses of all types throughout North America. It also operates in Europe, Asia and Latin America. The company designs, manufactures, implements corporate identity uniform programs, and provides entrance mats, restroom supplies, promotional products and first aid and safety products for diversified businesses. Notably, the company provides products and services through distribution and retail channels to small service and manufacturing companies as well as leading corporations.
Why Cintas (CTAS) Stock Might be a Great Pick
by Zacks Equity Research
Cintas (CTAS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Cintas (CTAS) Exhibits Strong Prospects Amid Challenges
by Zacks Equity Research
Cintas (CTAS) stands to gain from strength across its healthcare and hygiene end markets, acquired asset and shareholder-friendly policies. End-market challenges and high-debt are concerning.
Cintas (CTAS) Tops on Q3 Earnings, Gives Solid Sales View
by Zacks Equity Research
Cintas' (CTAS) Q3 results reflect the impacts of lower revenues as well as a decline in costs and expenses. The company anticipates Q4 revenues to improve sequentially.
Cintas (CTAS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 7.24% and 1.15%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Titan Machinery (TITN) to Report Q4 Earnings: What to Expect?
by Zacks Equity Research
Titan Machinery (TITN) fourth-quarter fiscal 2021 results are likely to reflect favorable agriculture market fundamentals, higher construction demand and efforts to control operating expenses.
MP Materials (MP) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
MP Materials' (MP) fourth-quarter results are likely to reflect higher production realized price owing to improved efficiency of its processing operations and higher average realized prices.
Will Cintas (CTAS) Keep Its Earnings Streak Alive in Q3?
by Zacks Equity Research
Cintas' (CTAS) Q3 earnings results to reflect the impacts of one less working day and the pandemic-related woes. The healthy demand in hygiene and healthcare markets is likely to have been appealing.
Should You Buy Cintas (CTAS) Ahead of Earnings?
by Zacks Equity Research
Cintas (CTAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Energy Fuels (UUUU) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Energy Fuels' (UUUU) fourth-quarter results are likely to reflect its decision to withhold uranium and vanadium sales until prices rise. A debt free balance sheet and cost cutting efforts will aid margins.
Cintas (CTAS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cintas (CTAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Hot Upcoming Earnings Charts
by Tracey Ryniec
Earnings season is winding down over the next 2 weeks but there are still incredible earnings charts still to come.
Why Cintas (CTAS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Cintas (CTAS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Ingersoll (IR) to Post Q4 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Ingersoll Rand's (IR) Q4 earnings are likely to have gained from solid product portfolio, the Albin Pump buyout and cost-control actions. Unfavorable product mix might have marred its performance.
Cintas (CTAS) Provides Third-Quarter Fiscal 2021 Projections
by Zacks Equity Research
Cintas (CTAS) third-quarter fiscal 2021 projections reflect the impacts of the pandemic and one less working day. Share buybacks and dividend payments are priority.
Why Is Cintas (CTAS) Down 2.1% Since Last Earnings Report?
by Zacks Equity Research
Cintas (CTAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Salesforce, HSBC, Honda Motor, Cintas and MarketAxess
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Salesforce, HSBC, Honda Motor, Cintas and MarketAxess
Top Research Reports for salesforce, HSBC & Honda Motor
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including salesforce.com, inc. (CRM), HSBC Holdings plc (HSBC) and Honda Motor Co., Ltd. (HMC).
Cintas (CTAS) Q2 Earnings Surpass Estimates, Sales Miss
by Zacks Equity Research
Cintas' (CTAS) Q2 results benefit from improved margin profile that offset the impact of a revenue decline. It refrains from providing projections for fiscal 2021 on the pandemic-led uncertainties.
Cintas (CTAS) Q2 Earnings Top Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 20.18% and -0.23%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Q4 Earnings Season Preview
by Sheraz Mian
The consensus expectation is for total S&P 500 earnings to decline -11% in Q4 from the same period last year on essentially flat revenues. This would follow the -7% decline in Q3 and -32.2% decline in Q2...
Cintas (CTAS) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas' (CTAS) Q2 earnings are expected to have gained from strength across its healthcare and hygiene end markets, Doritex business and cost control actions. Coronavirus-led issues might have hurt.
Cintas (CTAS) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Cintas (CTAS) will benefit from strength across its healthcare and hygiene end-markets, acquired asset and shareholder-friendly policies. The coronavirus outbreak-led market downturn is concerning.
Analysts Estimate Cintas (CTAS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Cintas (CTAS) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Is (CTAS) Outperforming Other Industrial Products Stocks This Year?
Analysts Estimate Cintas (CTAS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.